VK2735 (5mg/10mg)

What is VK2735?

VK2735 is an investigational peptide with GIP and GLP-1 receptor activity. The catalog offers 5mg and 10mg research vials. A shared receptor class does not make it identical to tirzepatide.

Listed vial contents: 5mg / 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

Researchers examine activation of both incretin receptors and compare responses in matched assays. The supplied sequence and chemical modifications must be established before attributing a clinical candidate's behavior to inventory.

What are the research questions?

• GIP and GLP-1 receptor responses
• Sequence-specific comparisons among dual agonists
• Understanding short-duration trial endpoints

What does the published work describe?

Bays and colleagues' VENTURE publication describes a randomized phase 2 trial with 13 weeks of treatment. It evaluated a defined VK2735 clinical formulation in adults with obesity or overweight. A short-duration trial does not establish long-term outcomes or equivalence to this research vial.

Experimental models in the cited papers

• VENTURE: randomized, placebo-controlled phase 2 human trial

What could future research explore?

Further work can compare dual-receptor responses and longer-term clinical endpoints. Direct comparator studies are needed before making superiority claims against other incretin compounds.

These are research directions, not established applications of the product sold here.

What are the limits of this evidence?

Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.

Study references

1. Bays HE, et al. Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. Obesity (Silver Spring). 2026. PMID 41508550

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. Generated sample reports illustrate the reporting flow and are not evidence of testing, purity or accreditation.